Methods: We conducted a Phase I/IIa clinical trial of VK-2019 as a single therapeutic agent in patients with advanced (recurrent or metastatic) NPC. An accelerated titration design allowed dose escalation to proceed rapidly from 60 mg/day to 1800 mg/day. Blood samples for detailed ...
02 Jun 2023 Efficacy, adverse events and pharmacokinetic data from a phase II trial in Nasopharyngeal cancer presented at the 59th Annual Meeting of the American Society of Clinical Oncology (ASCO-2023) 19 Oct 2020 Cullinan Oncology terminates phase I/II clinical trials in Nasopharyngeal cancer (...
为了满足上述读者提出的要求并结合最近对角膜塑形设计方面的一些理解,在CRT塑形镜的验配内容外,我们又整理了一些资料,包括VST塑形镜的弧段设计、塑形镜降幅设计原则、散光塑形镜验配、角膜塑形临床风险防控专家共识等与临床密切相关的内容,对原文重新优化整理后编写了《硬性角膜接触镜验配跟我学》(第2版)。 第2版优...